Stroke

The findings suggest the externally altered proprioceptive feedback in forced exercises may be increasing cortical engagement.

Treatment with tPA within 0 to 60 minutes of last known normal occurred for 33% of patients on mobile stroke units, compared to 3% who received standard management.

Here's what is coming soon to NeurologyLive.

Students share their experience in the virtual classroom, navigating new requirements, and the lessons learned from their position in a global pandemic.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending March 12, 2021.

A pair of cerebrovascular and neurosurgery experts discuss a novel approach to communicating hydrocephalus with an arachnoid granulation using a miniature implant, delivered via a percutaneous endovascular catheter.

Researchers found that the proportion of patients meeting DNC criteria suitable for organ donation increased after teleneurology use.

Increases in reperfusion treatment were the largest in lowest-volume hospitals, among rural residents, and among patients aged 85 years and older.

Here's what is coming soon to NeurologyLive.

Researchers found that higher NIHSS scores on admission and a successful first-pass effect were predictors of reaching early neurological improvement.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending March 5, 2021.

The assistant professor of neurology at Thomas Jefferson University discussed areas of poststroke care that need improvement including a more streamlined process.

Here's what is coming soon to NeurologyLive.

Neurology News Network for the week ending February 27, 2021.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending February 26, 2021.

Similar proportions of both in-clinic and telemedicine patients had modified Rankin scale score improvements.

The assistant professor of neurology at Thomas Jefferson University gave background on what other studies have observed brain implants for poststroke patients and how they differ from his work.

Here's what is coming soon to NeurologyLive.

Bijan Nejadnik, MD, chief medical officer, SanBio, also thanked neurological experts that collaborated on the phase 2 STEMTRA trial.

Researchers also found that during the COVID-19 pandemic, there were reduced rates of stroke quality of care measures.

The breakthrough designation gives BrainQ access to the new Medicare Coverage of Innovative Technology pathway.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending February 19, 2021.

Masahito Kawabori, MD, PhD, associate professor, Hokkaido University, discussed results of the phase 2 STEMTRA trial.

Investigators identified no additional benefit nor harm from the use of low-dose alteplase to treat patients with lacunar acute ischemic stroke compared to other subtypes of AIS.

The duo from Vanderbilt University discussed the lack of awareness for functional seizures, their differences in treatment, and what needs to change about their current management.